Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer
Conclusions: Our study revealed that a PIRDEG signature could be a candidate prognostic biomarker for predicting the overall survival (OS) of patients with BRCA.
Source: Frontiers in Genetics - Category: Genetics & Stem Cells Source Type: research
More News: Allergy & Immunology | Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Genetics | Study | Training | Universities & Medical Training